Elissa Prichep is Precision Medicine Lead at the World Economic Forum, and based in San Francisco. Her work focuses on developing and testing policies that will advance precision medicine approaches in emerging economies. She also manages the Forum’s Global Future Council on Biotechnology.

By background, Elissa worked in the bio-pharmaceutical industry bringing specialty therapeutics to market and worked for the Maryland State government developing and implementing business and economic policy. She most recently lead patient strategy and digital innovation for biosimilar immunology products at Merck, brought their ground-breaking immunotherapy cancer treatment (KEYTRUDA) to market and developed the company’s first 24/7 patient support program. Elissa was a Woodruff Fellow at Emory University’s Goizueta Business School, where she earned her MBA, and she received her BA from Cornell University. Elissa was named to the inaugural class of the 40 Under 40 in Cancer.